The migraine WHAT! study focusses on the role of hormones in women with migraine. WHAT stands for “Women, Hormones, Attacks and Treatment”.
Less benefits, more side effects
Women benefit less from triptans – migraine drugs – than men. In addition, women more often suffer from side effects. This was demonstrated in a study by the LUMC and Erasmus MC. Read more in this interview in Leidsch Dagblad (in Dutch).
Can migraine patients benefit from the oral contraceptive pill?
Each month WOMEN Inc. asks a researcher 5 questions. This month: Antoinette Maassen van den Brink, farmacologist and researcher from the Erasmus MC, about her research on the relationship between hormones and migraine. Read the full article here (in Dutch).
Women respond differently to treatment of migraine with triptans than men
Headache researchers from the Leiden University Medical Center (LUMC) and the Erasmus Medical Center (Erasmus MC) concluded that women more often experience headache recurrences after the intake op triptans and report more side effects. The results have been published in the journal Neurology. See for the full article the LUMC website.